Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biosign Technologies Inc acquires 100 pct of QLINE Solutions Inc


Wednesday, 8 Jan 2014 04:01pm EST 

Biosign Technologies Inc:Says the execution of a Share Purchase Agreement under which it has agreed to acquire 100 pct of the issued and outstanding shares of QLINE Solutions Inc, produces the QCARE Integrated Product Suite.Says on July 11, 2013 it had executed a term sheet pursuant to which it would acquire 51 pct of QLINE for a purchase price of $1.53 mln, to be paid by way of $630,000 in cash and the issuance of 18,000,000 common shares of Biosign at an ascribed value of $0.05 per share.Says on Nov. 8, 2013, the Company announced that it had entered into an amended term sheet pursuant to which it would increase the percentage of QLINE to be acquired from 51 pct to 72 pct. 

Company Quote

0.0050
0.0 +0.00%
17 Dec 2014